Caribou Biosciences's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Caribou Biosciences last closed at $0.4602 (-4.36%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -0.5×. Its overall grade ranks 617 of 738 stocks in Healthcare.
About this company
Caribou Biosciences last closed at $0.4602 (-4.36%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 617/738
Valuation grade C+
Related stocks
- Editas MedicineCompetitor
CRISPR 유전자편집 치료제 개발 경쟁사
- Intellia TherapeuticsCompetitor
CRISPR 기반 유전자편집 치료제 핵심 경쟁사
- Beam TherapeuticsCompetitor
차세대 유전자편집/베이스에디팅 경쟁사
About Caribou Biosciences
- What technical signals does Caribou Biosciences (CRBU) have?
- Caribou Biosciences current technical signals: no active technical signal.
- Is Caribou Biosciences a cup-and-handle pattern?
- No. Caribou Biosciences has no valid Cup signal right now.
- What published figures are available for Caribou Biosciences?
- Market cap: $43.01M. Trailing 12 months PER: -0.5×. Latest quarter PBR: 0.50×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Caribou Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.